A narrative review on vaccination rate and factors associated with the willingness to receive pneumococcal vaccine in Chinese adult population

References

• Chen Q, Wang L, Xie M, Li X, Recommendations for Influenza, Streptococcus pneumoniae Vaccination in Elderly People in China Writing Group, Geriatric Respiratory Group and Chinese Society of Geriatrics. Recommendations for influenza and Streptococcus pneumoniae vaccination in elderly people in China. Aging Med. 2020;3(1):4–8. doi:10.1002/agm2.12102.
   Google Scholar
• Drijkoningen JJC, Rohde GGU. Pneumococcal infection in adults: burden of disease. Clin Microbiol Infect. 2014;20:45–51. doi:10.1111/1469-0691.12461.
   PubMed Web of Science ®Google Scholar
• Zhou M, Zhan J, Kong N, Campy KS, Chen Y. Factors associated with intention to uptake pneumococcal vaccines among Chinese elderly aged 60 years and older during the early stage of COVID-19 pandemic. Psychol Health Med. 2022;27(1):91–105. doi:10.1080/13548506.2021.1905862.
   PubMed Web of Science ®Google Scholar
• Li Y, Lv Y, Xue F, Zhang XZ, Hu XJ, Yu T. Antimicrobial susceptibility surveillance of gram-positive bacteria from ministry of health national antimicrobial resistance investigation net (Mohnarin) 2011-2012. Chin J Clin Pharm. 2014;30:251–60.
   Google Scholar
• Qin Y, Yu H. Chinese prevention medicine association. [Technical guideline on application of pneumococcal vaccine in China (2012)]. Zhonghua Liu Xing Bing Xue Za Zhi. 2012;33:1101–10.
   PubMedGoogle Scholar
• Moberley S, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2013;1:CD000422. doi:10.1002/14651858.CD000422.pub3.
   PubMed Web of Science ®Google Scholar
• Tsai Y-H, Hsieh M-J, Chang C-J, Wen Y-W, H-c H, Chao Y-N, Huang Y-C, Yang C-T, Huang -C-C. The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old—Taiwan’s PPV vaccination program. Vaccine. 2015;33(25):2897–902. doi:10.1016/j.vaccine.2015.04.068.
   PubMed Web of Science ®Google Scholar
• Diao W, Shen N, Yu P, Liu B, He B. Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: a systematic review and meta-analysis of randomized trials. Vaccine. 2016;34(13):1496–503. doi:10.1016/j.vaccine.2016.02.023.
   PubMed Web of Science ®Google Scholar
• Xu Y, Dong BR. Effectiveness of 23-valent pneumococcal polysaccharide vaccine to prevent LRTIs in the elderly population. Chin J Vaccines Immuniz. 2005;11:287–91.
   Google Scholar
• Wang Y, Cheng M, Wang S, Wu F, Yan Q, Yang Q, Li Y, Guo X, Fu C, Shi Y, et al. Vaccination coverage with the pneumococcal and influenza vaccine among persons with chronic diseases in Shanghai, China, 2017. BMC Public Health. 2020;20(1):359. doi:10.1186/s12889-020-8388-3.
   PubMed Web of Science ®Google Scholar
• Liu S, Xu E, Liu Y, Xu Y, Wang J, Du J, Zhang X, Che X, Gu W. Factors associated with pneumococcal vaccination among an urban elderly population in China. Hum Vaccin Immunother. 2014;10(10):2994–99. doi:10.4161/21645515.2014.972155.
   PubMed Web of Science ®Google Scholar
• Zhang M, Chen H, Wu F, Li Q, Lin Q, Cao H, Zhou X, Gu Z, Chen Q. Heightened willingness toward pneumococcal vaccination in the elderly population in Shenzhen, China: a Cross-Sectional study during the COVID-19 pandemic. Vaccines (Basel). 2021;9(3):212. doi:10.3390/vaccines9030212.
   PubMed Web of Science ®Google Scholar
• Williams WW, P-j L, O’Halloran A, Kim DK, Grohskopf LA, Pilishvili T, Skoff TH, Nelson NP, Harpaz R, Markowitz LE, et al. Surveillance of vaccination coverage among adult populations — United States, 2014. MMWR Surveill Summ. 2016;65(1):1–36. doi:10.15585/mmwr.ss6501a1.
   PubMed Web of Science ®Google Scholar
• Pneumococcal Polysaccharide Vaccine (PPV) coverage report, England, April 2020 to March 2021 [Internet]. [accessed 2022 Mar 09] https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1035189/hpr1921-ppv-vc.pdf
   Google Scholar
• Yan-qin PENG, Zheng YU, Guo-dong WANG. Study on the pharmacoeconomics of 23-valent pneumococcal polysaccharide vaccine in elderly:A systematic review. China Pharm. 26:36.
   Google Scholar
• Yang J, Atkins KE, Feng L, Pang M, Zheng Y, Liu X, Cowling BJ, Yu H. Seasonal influenza vaccination in China: landscape of diverse regional reimbursement policy, and budget impact analysis. Vaccine. 2016;34(47):5724–35. doi:10.1016/j.vaccine.2016.10.013.
   PubMed Web of Science ®Google Scholar
• GuoHui Z, DongYi Z, NianMin S, Xing A, YunHua B. Pneumonia vaccination coverage and influencing factors among part of community elderly in Chaoyang District, Beijing City, China. Chin J Biol. 2013;26:93–95.
   Google Scholar
• You ZJ, Lin B, Gao Z. Pneumonia vaccination coverage and influencing factors among community elderly in Qingpu District, Shanghai City, China. Med Health Care. 2015;23:89.
   Google Scholar
• Zhu B, Huang RN, Yang RP. Investigation on pneumonia vaccination coverage and influencing factors among elderly population with permanent residence of Chengdu, China. J Prev Med Inf. 2017;33(1):75–80.
   Google Scholar
• Liu Y, Xu Y, Wang J, Che X, Gu W, Du J, Zhang X, Zhang X, Jiang W, Chen J, et al. Vaccination pattern of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in Hangzhou, China: a coverage and adverse events following immunization of different age groups. Hum Vaccin Immunother. 2021;17(1):157–61. doi:10.1080/21645515.2020.1765620.
   PubMed Web of Science ®Google Scholar
• Hong Kong Information Services Department. LCQ17: pneumococcal vaccination for elderly persons. 2015b. [accessed 2022 Mar 11] http://www.info.gov.hk/gia/general/201511/18/P201511180642.htm.
   Google Scholar
• Sun X, Tang Y, Ma X, Guo X, Huang Z, Ren J, Qiu J, Jiang H, Lu Y. Cost-Effectiveness analysis of 23-Valent pneumococcal polysaccharide vaccine program for the elderly aged 60 Years or Older in Shanghai, China. Front Public Health. 2021;9:647725. doi:10.3389/fpubh.2021.647725.
   PubMed Web of Science ®Google Scholar
• Kyaw MH, Rose CE, Fry AM, Singleton JA, Moore Z, Zell ER, Whitney CG. Active bacterial core surveillance program of the emerging infections program network. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis. 2005;192(3):377–86. doi:10.1086/431521.
   PubMed Web of Science ®Google Scholar
• Qiu YP, Zhao K, Li X, Shi LW, Guo WD, Qi XR, Sui BY, Zhou RM. Health economic evaluation of a 23 value pneumococcal polysaccharide vaccination pilot programme among elderly chronic obstructive pulmonary disease patients in China. Zhonghua Yu Fang Yi Xue Za Zhi. 2016;50(12):1074–78. doi:10.3760/cma.j.0253-9624.2016.12.010.
   PubMedGoogle Scholar
• Chiou W-Y, Lee M-S, Hung S-K, Lin H-Y, Y-c L, Hsu F-C, Tsai S-J, C-Y L. Effectiveness of 23-valent pneumococcal polysaccharide vaccine on elderly long-term cancer survivors: a population-based propensity score matched cohort study. BMJ Open. 2018;8(5):e019364. doi:10.1136/bmjopen-2017-019364.
   PubMed Web of Science ®Google Scholar
• C-y L, Chen L-C, Lin H-Y, Lee M-S, Hung S-K, Lai C-L, Huang L-W, B-h Y, Hsu F-C, Chiou W-Y. Impact of 23-valent pneumococcal polysaccharide vaccination on the frequency of pneumonia-related hospitalization and survival in elderly patients with prostate cancer: a seven-year nationwide matched cohort study. Cancer. 2020;127(1):124–36. doi:10.1002/cncr.33203.
   PubMed Web of Science ®Google Scholar
• WHO Publication. Pneumococcal vaccines WHO position paper - 2012 - recommendations. Vaccine. 2012;30(32):4717–18. doi:10.1016/j.vaccine.2012.04.093.
   PubMed Web of Science ®Google Scholar
• Advisory Committee on Immunization Practices. Recommended Adult Immunization Schedule for ages 19 years or older. 2019 6 [Internet]. [accessed 2022 Mar 15] www.cdc.gov/vaccines/pubs/surv-manual
   Google Scholar
• Fan J, Cong S, Wang N, Lyu XL, Bao HL, Wang BH, Feng YJ, Yang T, Wang LH, Fang LW. Pneumococcal vaccination rate in chronic obstructive pulmonary disease patients aged 40 years or older in China, 2014-2015. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(7):1028–33. doi:10.3760/cma.j.cn112338-20200124-00056.
   PubMedGoogle Scholar
• Xueli YUAN, Rui WANG, Ying FU, Kui XIE, Wenqing NI, Jian XU. Analysis of knowledge, attitude, behavior, and practice and the influencing factors of pneumococcal vaccination in type 2 diabetes mellitus patients. Chin J Health Manage. 2019;6:46–50.
   Google Scholar
• Huang J, Bai Y, Ding H, Wang B, Ngai CH, Kwok K-O, Wong ELY, Wong MCS, Yeoh E-K. Acceptance of pneumococcal vaccination in older adults: a general population-based survey. Vaccine. 2021;39(47):6883–93. doi:10.1016/j.vaccine.2021.10.024.
   PubMed Web of Science ®Google Scholar
• Mengmeng Z, Chunxi D, Caihong C, Peiqing B. Analysis of influencing factors of pneumonia vaccination among the elderly in Jiashan County. Chin J Crit Care Med. 2016;36(2):139–141.
   Google Scholar
• Yanhua Y, Shujun Z, Zhiwei L, Mingli F, Jie Y, Lidong G. Study on the vaccination rate and influencing factors of elderly people in pneumonia vaccine, Changsha. Chin Preventive Med. 2019;20:623–26.
   Google Scholar
• Xiaodong S, Xiang G, Jia R, Yueping W, Qichao P, Genming Z. Knowledge and attitude toward pneumonia and pneumococcal polysaccharide vaccine among the elderly in Shanghai, China: a crosssectional questionnaire survey. J Pulm Respir Med. 2016;06(2):2. doi:10.4172/2161-105X.1000330.
   Google Scholar
• Jian C, Jianxiong X, Yanshan C, Yong H, Wenhui L. Analysis of influencing factors of pneumonia vaccination among the elderly in Guangzhou. J Pract Med. 2016;32(16):2740–2742.
   Google Scholar
• Liangbin L. Investigation on the vaccination of 23 valent pneumococcal polysaccharide vaccine among the elderly in Zhengzhou high tech Zone [J]. Henan J Preventive Med. 2019;30:182–183,198.
   Google Scholar
• Zhang Q. Analysis of pneumonia vaccination and its influencing factors among the elderly in the urban area of Ninghai County. World’s Latest Med Inf Abstr. 2016;16:56.
   Google Scholar
• Minghong X, Yun L, Suwan Y. Analysis of vaccination and influencing factors of pneumonia among the elderly in Baoji City. J Med Pest Control. 2015;31(3):333–335.
   Google Scholar
• Xiaoying CHEN, Zhang Y, Guangzhi LI, Linjiang WANG, CHEN S, Feng LIU. Investigation on the pneumonia vaccination willingness and its influence factors among elderly residents over 60 years in Xi’an City. Public Health Preventive Med. 2016;27(6):21–24.
   Google Scholar
• Wenhong W, Yiping H, Wenjuan L, Jiayi Y, Tao W, Bing G. Investigation on Influencing Factors of pneumonia vaccination among the elderly in Longjiang Town, Shunde District. Mod Diagnosis Treat. 2019;30(22):3938–3939.
   Google Scholar
• Jiang Y, Zhang X, Lv Q, Qi J, Guo X, Wei Q, Liao Z, Lin Z, Gu J. Knowledge, attitude, and practice regarding infection and vaccination in patients with rheumatic diseases in China. Hum Vaccin Immunother. 2019;15(5):1100–05. doi:10.1080/21645515.2019.1568160.
   PubMed Web of Science ®Google Scholar
• Siu JY. Perceptions of seasonal influenza and pneumococcal vaccines among older chinese adults. Gerontologist. 2021;61(3):439–48. doi:10.1093/geront/gny139.
   Web of Science ®Google Scholar
• Mui LWH, Chan AYS, Lee A, Lee J, de Lencastre H. Cross-sectional study on attitudes among general practitioners towards pneumococcal vaccination for middle-aged and elderly population in Hong Kong. PLoS One. 2013;8(11):e78210. doi:10.1371/journal.pone.0078210.
   PubMed Web of Science ®Google Scholar
• Hou Z, Chang Null J, Yue D, Fang H, Meng Q, Zhang Y. Determinants of willingness to pay for self-paid vaccines in China. Vaccine. 2014;32(35):4471–77. doi:10.1016/j.vaccine.2014.06.047.
   PubMed Web of Science ®Google Scholar
• Lu X, Lu J, Zhang L, Mei K, Guan B, Lu Y. Gap between willingness and behavior in the vaccination against influenza, pneumonia, and herpes zoster among Chinese aged 50–69 years. Expert Rev Vaccines. 2021;20(9):1147–52. doi:10.1080/14760584.2021.1954910.
   PubMed Web of Science ®Google Scholar
• Qiuxia C, Hongwei W, Chiqiang L, Shengna L, Xinru L. Investigation on influenza and pneumonia vaccination willingness of patients with chronic diseases in Chancheng District. Chin Community Doctors. 2021;37(35):156–157.
   Google Scholar
• Wagner AL, Sun X, Montgomery JP, Huang Z, Boulton ML, Xu J. The impact of residency and urbanicity on haemophilus influenzae Type B and pneumococcal immunization in Shanghai Children: a retrospective cohort study. PLoS ONE. 2014;9(5):e97800. doi:10.1371/journal.pone.0097800.
   PubMed Web of Science ®Google Scholar
• Lin Z, Jing G, Dingxi B, Xinyu C. A meta analysis of pneumococcal vaccination willingness among Chinese residents. J Preventive Med. 2021;33(9):935–939.
   Google Scholar
• Paguio JA, Yao JS, Dee EC. Silver lining of COVID-19: heightened global interest in pneumococcal and influenza vaccines, an infodemiology study. Vaccine. 2020;38(34):5430–35. doi:10.1016/j.vaccine.2020.06.069.
   PubMed Web of Science ®Google Scholar
• Kong G, Lim N-A, Chin YH, Ng YPM, Amin Z. Effect of COVID-19 pandemic on influenza vaccination intention: a meta-analysis and systematic review. Vaccines. 2022;10(4):606. doi:10.3390/vaccines10040606.
   PubMed Web of Science ®Google Scholar
• Jiang N, Yang C, Yu W, Luo L, Tan X, Yang L. Changes of COVID-19 knowledge, attitudes, practices and vaccination willingness among Residents in Jinan, China. Front Public Health. 2022;10:917364. doi:10.3389/fpubh.2022.917364.
   PubMed Web of Science ®Google Scholar
• Zhao D, Gai Tobe R, Cui M, He J, Wu B. Cost-effectiveness of a 23-valent pneumococcal polysaccharide vaccine immunization programme for the elderly in Shanghai, China. Vaccine. 2016;34(50):6158–65. doi:10.1016/j.vaccine.2016.11.003.
   PubMed Web of Science ®Google Scholar